Litigation Details for Novartis Pharmaceuticals Corporation v. Lupin Inc. (D. Del. 2021)
✉ Email this page to a colleague
Novartis Pharmaceuticals Corporation v. Lupin Inc. (D. Del. 2021)
Docket | ⤷ Subscribe | Date Filed | 2021-07-29 |
Court | District Court, D. Delaware | Date Terminated | 2023-12-05 |
Cause | 35:271 Patent Infringement | Assigned To | |
Jury Demand | None | Referred To | |
Parties | LUPIN INC. | ||
Patents | 8,575,146 | ||
Attorneys | Timothy Devlin | ||
Firms | Devlin Law Firm LLC | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Novartis Pharmaceuticals Corporation v. Lupin Inc.
Details for Novartis Pharmaceuticals Corporation v. Lupin Inc. (D. Del. 2021)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
0000-00-00 | External link to document | |||
2021-07-29 | 3 | ANDA Form | than 06/14/2021. Date of Expiration of Patent: 12/2/2030 (8,575,146). Thirty Month Stay Deadline: No Earlier… Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) …2021 5 December 2023 1:21-cv-01105 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
2021-07-29 | 4 | Patent/Trademark Report to Commissioner of Patents | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,575,146. (mal) (Entered: 07…2021 5 December 2023 1:21-cv-01105 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |